Holen Sie sich die Stockscreener-App
82.80
3.59%
2.87
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
DexCom (DXCM) to Launch Dexcom G7 15 Day CGM System in Canada Ne - GuruFocus
Dexcom launches 15-day glucose monitor in Canada next month By Investing.com - Investing.com India
Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in NovemberDexCom, Inc. - DexCom, Inc. - Investor Relations
Dexcom G7 15 Day glucose monitor to launch in Canada in November - StreetInsider
What to expect from DexCom’s (DXCM) Q3 earnings - Yahoo Finance
Here’s How Much You Would Have Made Owning DexCom Stock In The Last 15 Years - Benzinga
Our Dexcom Pick Had a Minor Setback. It’s Still a Diabetes Winner. - Barron's
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Is DexCom (DXCM) Cheap After CONNECT Trial Results Backed G7 Adoption? - Simply Wall Street
DexCom Gears Up to Report Q3 Results: How to Play the Stock? - Zacks Investment Research
DexCom Gears Up to Report Q3 Results: How to Play the Stock? - Zacks Investment Research
DexCom Gears Up to Report Q3 Results: How to Play the Stock? - TradingView
Leerink Partners Adjusts Price Target on DexCom to $87 From $94 - marketscreener.com
Dexcom Inc Lobbying Profile, 2020 - OpenSecrets
Form 144 DEXCOM For: 26 October By Investing.com - Investing.com Nigeria
DexCom, Inc. (DXCM) Options ChainYahoo Finance - Yahoo! Finance Canada
DexCom, Inc. Estimates – NASDAQ:DXCM - TradingView
Why Is DexCom (DXCM) In Focus After Its G7 Trial Reached NEJM? - Yahoo Finance
DexCom Inc (DXCM) Shares Fall 6.4% -- What GF Score of 95 Tells Investors - GuruFocus
Precision Trading with Dexcom Inc. (DXCM) Risk Zones - Stock Traders Daily
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DexCom (DXCM) Shares Fall 6.5% Amid Broader Market Gains on Octo - GuruFocus
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers - ChartMill
Global Digital Health and Remote Patient Monitoring Strategic Market Report, 2026-2031 | 20.2% CAGR to $80.8 Billion as Connected Care and Wearables Scale - GlobeNewswire Inc.
DexCom Inc. Company & People | DXCM.USD - Barron's
DXCM.USD | DexCom Inc. Stock Overview (Switzerland: SWX) - Barron's
DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study - Zacks Investment Research
DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study - Yahoo! Finance Canada
Form 4 DexCom Inc: Michael Jon Brown (EVP Chief Legal Compliance Off) For: 15 October By Investing.com - Investing.com South Africa
Dexcom EVP Michael Brown sells $145,316 in company stock - Investing.com
Dexcom class action lawsuits claim ShinyHunters stole health data - Top Class Actions
DexCom: The 15-Day Sensor Lowered The Cost Curve Before The Type 2 Wave Arrives - Seeking Alpha
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
Dexcom faces a class action over an alleged data breach that ShinyHunters claimed responsibility for. - Claim Depot
Vaso Stock Surges 149% in a Year: What's Behind the Rally? - TradingView
Vaso Stock Surges 149% in a Year: What's Behind the Rally? - Zacks Investment Research
A Look at DexCom Inc (DXCM) After 5.1% Gain -- GF Value $103.59 vs Price $87.71 - GuruFocus
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
DexCom gains as NEJM publication boosts Medicare coverage hopes - TradingView
Landmark Dexcom CONNECT Study Published in The New England Journ - GuruFocus
Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin - Dexcom
DexCom Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DexCom Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Yahoo Finance
DexCom (NASDAQ:DXCM): Affordable Growth at a Reasonable Valuation - ChartMill
Here's What to Expect From DexCom’s Next Earnings Report - inkl
Here's What to Expect From DexCom’s Next Earnings Report - Yahoo Finance
DexCom Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
0.16%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):